Cell Tribune
CellTribune.com provides business and research news updates for the cell and gene therapy industry. CellTribune follows the companies and people who drive innovation in this exciting technology. The goal of CellTribune is to be recognized as the media leader and the go-to source for originally-reported, quality news coverage in this industry. We strive to become the link between budding companies, analysts and institutional investors. Submit your press release to Cell Tribune for immediate publication.
Advaxis and UCLA Enter Collaboration for Glioblastoma Immunotherapy Discovery Research
Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced a research collaboration agreement...
GSK and Lyell Immunopharma join forces to develop the next generation...
Collaboration will combine Lyell’s technologies with GSK’s pipeline of cell therapies and manufacturing capability
LONDON, UK and SAN FRANCISCO, CA, USA I October 08,...
ViaCyte Presented Preliminary PEC-Direct Clinical Data at Cell & Gene Meeting...
First demonstration of insulin production in patients from a stem cell-derived islet replacement therapy SAN DIEGO, October 3, 2019 – ViaCyte, Inc., a privately-held regenerative medicine company,...
Center for Beta Cell Therapy in Diabetes and ViaCyte Announce Start...
The Center for Beta Cell Therapy in Diabetes, coordinator of an international consortium in translational medicine in diabetes, and ViaCyte, Inc., a privately held regenerative...
Immunotherapy gel targets lingering tumor cells after surgery
Sprayable gel unleashes antibodies at surgery sites to prevent cancer recurrence and metastasis
Malignant cells often get left behind when a tumor is removed during...
Wuxi AppTec to expand facilities and operations to support cell and...
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations, announces the expansion of its...
Positive 12-Month Data on BioCardia’s Investigational CardiAMP Cell Therapy System for...
CHICAGO & SAN CARLOS, Calif.--(BUSINESS WIRE)--BioCardia®, Inc. , a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced positive 12...
Berkeley Lights Closes $95 Million Funding Round To Expedite Commercial Expansion...
EMERYVILLE, Calif., Oct. 15, 2018 /PRNewswire/ -- Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today the completion of a $95 million financing led by Nikon...
SQZ Biotech And Roche Expand Cell Therapy Partnership
October 15, 2018 – Watertown, MA - SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the...
CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy
ViaCyte’s attempts to develop a stem cell therapy for diabetes have been stymied by the immune system, which recognizes the implanted cells as foreign....
